Cargando…
Serum Cystatin C as a Biomarker in Diffuse Large B-Cell Lymphoma
Elevated serum levels of cystatin C are found to be related to poor outcome and metastatic potential of some malignant disorders. To evaluate the clinical prominence of serum cystatin C in diffuse large B-cell lymphoma (DLBCL), blood samples were obtained from 58 patients at the time of diagnosis an...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388146/ https://www.ncbi.nlm.nih.gov/pubmed/28282874 http://dx.doi.org/10.3390/scipharm85010009 |